UK scientists developing Ebola vaccine that could be ready for trials in months
The rare species of Ebola involved - known as Bundibugyo - kills around a third of those infected and has no proven vaccine yet.
www.bbc.comHere are the latest updates on Ebola vaccines from reputable sources:
-
UK researchers are developing an Ebola vaccine targeting Bundibugyo; trial-ready doses could be available for clinical testing in the next 2–3 months, though animal data and other uncertainties remain [BBC, May 22, 2026]. This work uses the ChAdOx1 platform, adapted from previous Covid-19 vaccine technology [BBC, May 22, 2026]. Source: BBC article on UK scientists developing an Ebola vaccine [web: BBC 2026-05-22].
-
A separate effort in Uganda marks a historic milestone: the first-ever clinical efficacy trial for a vaccine against the Ebola Sudan virus, accelerated to happen during an outbreak with rapid regulatory and ethical clearance (outbreak confirmed Jan 30; trial readiness within 4 days). This represents a pioneering approach to emergency vaccine trials [WHO press release, Feb 2, 2025]. Source: WHO page on the Sudan Ebola vaccine trial in Uganda [web: WHO 2025-02-02].
-
The World Health Organization has warned that, while there are candidates in development, timelines are uncertain and animal data is often needed to confirm efficacy before broader rollout. Some candidates could reach clinical testing in two to three months, but substantial uncertainty remains due to developmental and regulatory considerations [BBC, May 20, 2026]. Source: BBC Ebola vaccine timeline and WHO context [web: BBC 2026-05-20].
-
Historical context: Past Ebola vaccines have included rVSV-ZEBOV (Merck) used in outbreaks under compassionate use, and other candidates reached various stages of development and testing. These examples illustrate the trajectory from experimental vaccines to emergency use during outbreaks [Smithsonian Magazine 2018; BBC background on past vaccines]. Sources: Smithsonian Magazine overview of experimental Ebola vaccines and BBC background on Ebola vaccine development [web: Smithsonian 2018-05-16], [web: BBC Ebola vaccine background].
If you’d like, I can assemble a concise, sourced timeline of each candidate’s development stage, regulatory status, and major trial results to date, and I can add a short explainer on how the ChAdOx1 platform works in this context. Would you like that?